American Lung Association

Chicago – September 18, 2026 -- The American Lung Association has launched a national campaign to help patients and caregivers recognize the early warning signs of progressive pulmonary fibrosis (PPF), timed to World Interstitial Lung Disease Day.

PPF describes worsening lung scarring that can occur in people living with an interstitial lung disease (ILD), a group of more than 200 conditions that cause inflammation or scarring of the lungs. Harold Wimmer, President and CEO of the American Lung Association, said the causes range from autoimmune diseases to environmental or occupational exposures, or remain unknown, but all share the risk that scarring can worsen over time.

Chicago – September 13, 2026 -- The American Lung Association is expanding its Awareness, Trust and Action campaign to encourage more lung cancer patients to ask their doctors about clinical trials as a treatment option.

Every current lung cancer treatment originated in a clinical trial

"Clinical trials provide the most promising way to improve treatment outcomes and continue advancements in lung cancer care and survivorship," said Harold Wimmer, President and CEO of the American Lung Association. He said the organization wants patients and caregivers to discuss all treatment options, including trials, with their healthcare providers.